Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

oxLDL in Diabetes Mellitus Patients and Disease Periodontal

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Link salvestatakse lõikelauale
StaatusValmis
Sponsorid
Universidade Estadual Paulista Júlio de Mesquita Filho
Kaastöötajad
LabviVale

Märksõnad

Abstraktne

Periodontal disease (PD) and diabetes mellitus type 2 (DM2) have the same inflammatory etiopathogenesis and demonstrate a bidirectional relationship, for DM2 affects the severity of PD, and this may contribute to the overall inflammatory burden of the individual, influencing the natural course DM2. The aim of this study is to establish whether individuals with DM with or without chronic periodontitis have an increase in oxLDL and what is the influence of periodontal treatment in the reduction of oxLDL with consequent improvement in Diabetes Mellitus parameters.

Kirjeldus

Periodontal disease (PD) and diabetes mellitus type 2 (DM2) have the same inflammatory etiopathogenesis and demonstrate a bidirectional relationship, for DM2 affects the severity of PD, and this may contribute to the overall inflammatory burden of the individual, influencing the natural course DM2. The aim of this study is to establish whether individuals with DM with or without chronic periodontitis have an increase in oxLDL and what is the influence of periodontal treatment in the reduction of oxLDL with consequent improvement in Diabetes Mellitus parameters. 44 patients will be divided into 2 groups: Diabetic Patients with Chronic Periodontitis (DM2DP) and Diabetic Patients without Chronic Periodontitis (DM2). The DM2DP group will receive periodontal debridement and DM2 group will be treated with supragingival scaling. Both groups receive board control every 3 months. At baseline, 3 and 6 months after treatment, will be held making the clinical periodontal parameters (plaque index, gingival index, probing depth, gingival recession relative clinical attachment level and Periodontal Inflamed Surface Area (PISA) index) and blood collection for assessment serum inflammatory markers (oxLDL, LDL, HDL, total cholesterol, triglyceride, Interleukin (IL) IL-6, IL-8, IL-10, Tumor Necrosis Factor (TNF-α) and CRP). Biochemical analyzes will be carried out by Z-scan technique. The data obtained before and after periodontal therapy will be analyzed using the Shapiro-Wilk test.

Kuupäevad

Viimati kinnitatud: 10/31/2018
Esmalt esitatud: 02/05/2017
Hinnanguline registreerumine on esitatud: 06/21/2017
Esmalt postitatud: 06/25/2017
Viimane värskendus on esitatud: 11/10/2018
Viimati värskendus postitatud: 11/13/2018
Õppe tegelik alguskuupäev: 05/01/2016
Eeldatav esmane lõpetamise kuupäev: 08/25/2016
Eeldatav uuringu lõpetamise kuupäev: 01/27/2017

Seisund või haigus

Type 2 Diabetes Mellitus With Periodontal Disease

Sekkumine / ravi

Procedure: Type 2 diabetes mellitus and periodontitis

Faas

-

Käerühmad

ArmSekkumine / ravi
Sham Comparator: Type 2 diabetes mellitus and periodontitis
periodontal debridement in a single session.
Procedure: Type 2 diabetes mellitus and periodontitis
Debridement in a single session in which patients will be anesthetized and receive scaling and root planing with ultrasound equipment .
No Intervention: Type 2 diabetes mellitus and without periodontitis
maintained every three months.

Abikõlblikkuse kriteeriumid

Õppimiseks sobivad vanused 35 Years To 35 Years
Uuringuks kõlblikud soodAll
Võtab vastu tervislikke vabatahtlikkeJah
Kriteeriumid

Inclusion Criteria:

- individuals older than 35 years with DM2 diagnosed for more than five years and HbA1c between 7% and 11%;

- be diagnosed with generalized chronic periodontitis: present at least 6 sites with periodontal pocket and loss of insertion above 5mm and two more bags with loss of insertion above 6mm;

- present at least 20 teeth;

- agree to participate in the study and sign the informed consent form

Exclusion Criteria:

- patients with cardiovascular diseases, cancer, gastrointestinal disorders, skin diseases, pregnancy, lactation, smoking, arthritis, lupus or other diseases of inflammatory origin;

- have undergone periodontal treatment in the last 12 months;

- have made use of antioxidant supplements, anti-inflammatories, or antibiotics within the previous 3 months;

- make use of medications that can alter the marking and concentration of oxLDL, for example, statins;

- have changed the medication for glycemic control in the last 3 months;

- present dental elements with pulpal or periapical inflammation.

Tulemus

Esmased tulemusnäitajad

1. Probing depth change [baseline, 90 and 180 days]

The change in the probing depth will be measure in millimeters before and after the treatment.

Sekundaarsed tulemusmõõdud

1. oxLDL concentration Change [baseline and 180 days]

Change in concentration of oxLDL will be measured before and treatment.

2. LDL, HDL, Total cholesterol, Triacylglycerol [baseline and 180 days]

Blood concentration (g/ml) will be measured before and after periodontal therapy.

3. Plaque index [baseline, 90 and 180 days]

Number of teeth affected before and after periodontal treatment

4. Gingival index [baseline, 90 and 180 days]

number of teeth affected before and after periodontal treatment

5. Gingival Recession [baseline, 90 and 180 days]

Evaluated in millimeters before and after the treatment.

6. Clinical Attachment Level [baseline, 90 and 180 days]

Evaluated in millimeters before and after the treatment.

Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge